{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T18:34:06Z","timestamp":1789842846196,"version":"4.0.1"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":57,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"State Key Laboratory of Neurology and Oncology Drug Development","award":["SKLSIM-F-2025113"],"award-info":[{"award-number":["SKLSIM-F-2025113"]}]},{"name":"Anhui Provincial Department of Education Key Scientific Research Project","award":["2025AHGXZK31521"],"award-info":[{"award-number":["2025AHGXZK31521"]}]},{"name":"Anhui Province Youth Teacher Training Action Project","award":["YQYB2024043"],"award-info":[{"award-number":["YQYB2024043"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Male sexual dysfunction (MSD) can induce or exacerbate depressive symptoms, and MSD caused by antidepressants may further aggravate the depressive symptoms of patients. However, real-world evidence regarding the association between different antidepressants and MSD remains insufficient. This study aims to systematically analyze the differences in the association between antidepressants and MSD, by utilizing the U.S. Food and Drug Administration Adverse Event Reporting System.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Adverse drug events (ADEs) for male patients using antidepressants were retrieved. Adverse drug events were classified using the Standardized MedDRA Query. Disproportionality analysis was performed using reporting odds ratio (ROR), proportional reporting ratio (PRR), multi-item gamma-Poisson shrinker, and Bayesian confidence propagation neural network. The time-to-onset of MSD for each drug and the inclusion of MSD information in the drug labels were also analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among the 28 included drugs, 24 drugs reported MSD, 18 drugs simultaneously satisfied the positive signal criteria of all 4 algorithms. Sertraline had the highest number of MSD (988 cases), accounting for 6.22% of its total 15\u2009875 cases. Escitalopram showed the strongest signal on all 4 algorithms [ROR: 13.67, PRR: 13.19, lower limit of 95% CI of empirical Bayes geometric mean (EBGM05): 12.19, lower limit of 95% CI of the information component (IC025): 3.59]. The time-to-onset of MSD for most antidepressant drugs followed an \u201cEarly failure\u201d model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study employed 4 algorithms to detect and evaluate potential association signals between antidepressants and MSD. Among the 28 antidepressants analyzed, 18 demonstrated significant associations with MSD. Beyond traditional selective serotonin reuptake inhibitors, the signal strength of MSD associated with other classes of antidepressants should not be overlooked.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/sexmed\/qfag082","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T11:51:56Z","timestamp":1786535516000},"source":"Crossref","is-referenced-by-count":1,"title":["Differential signal strength of male sexual dysfunction associated with antidepressants: a disproportionality analysis of FAERS database"],"prefix":"10.1093","volume":"14","author":[{"given":"Jian","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Pharmacy, The First Affiliated Hospital of Bengbu Medical University , Bengbu 233004 ,","place":["China"]},{"name":"School of Pharmacy, Bengbu Medical University , Bengbu 233030 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The First Affiliated Hospital of Bengbu Medical University , Bengbu 233004 ,","place":["China"]},{"name":"School of Pharmacy, Bengbu Medical University , Bengbu 233030 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohu","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The First Affiliated Hospital of Bengbu Medical University , Bengbu 233004 ,","place":["China"]},{"name":"School of Pharmacy, Bengbu Medical University , Bengbu 233030 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0769-9363","authenticated-orcid":false,"given":"Lingti","family":"Kong","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The First Affiliated Hospital of Bengbu Medical University , Bengbu 233004 ,","place":["China"]},{"name":"School of Pharmacy, Bengbu Medical University , Bengbu 233030 ,","place":["China"]},{"name":"State Key Laboratory of Neurology and Oncology Drug Development , Nanjing 210044 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"key":"2026082813453152600_ref1","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s40264-025-01626-6","article-title":"Sexual dysfunctions associated with proton pump inhibitors: insights from VigiBase, the World Health Organization Pharmacovigilance Database","volume":"49","author":"Crisafulli","year":"2025","journal-title":"Drug Saf"},{"key":"2026082813453152600_ref2","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1039\/d5fo03860j","article-title":"Oyster hydrolysate via dynamic enzymolysis ameliorates male sexual dysfunction in mice","volume":"17","author":"Chunli","year":"2025","journal-title":"Food Funct"},{"issue":"3","key":"2026082813453152600_ref3","doi-asserted-by":"publisher","first-page":"qfaf048","DOI":"10.1093\/sexmed\/qfaf048","article-title":"Efficacy of Chinese herbal medicine in the treatment of anxiety and depression in male sexual dysfunction: a systematic review and meta-analysis","volume":"13","author":"Xie","year":"2025","journal-title":"Sex Med"},{"issue":"12","key":"2026082813453152600_ref4","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1038\/s41443-025-01072-z","article-title":"Associations between self-reports of physical activity, interoceptive awareness, autonomic regulation, premature ejaculation, and erectile dysfunction in Chinese men","volume":"37","author":"Caoyuan","year":"2025","journal-title":"Int J Impot Res"},{"issue":"8","key":"2026082813453152600_ref5","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1080\/00224499.2024.2432608","article-title":"Predictors of sexual dysfunction, associated distress, and sexual satisfaction among male and female patients living with anxiety disorders in Denmark","volume":"62","author":"Strizzi","year":"2025","journal-title":"J Sex Res"},{"key":"2026082813453152600_ref6","doi-asserted-by":"publisher","first-page":"7597","DOI":"10.1007\/s00210-025-04900-7","article-title":"A 24-year pharmacovigilance study on sex differences in adverse drug reactions to antidepressant drugs","volume":"399","author":"Johanna","year":"2025","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"2026082813453152600_ref7","doi-asserted-by":"publisher","first-page":"1651654","DOI":"10.3389\/fphar.2025.1651654","article-title":"Synergistic effect of Chaihu-Shugan-San combined with paroxetine tablets in the treatment of acquired premature ejaculation: study protocol for a randomized controlled proof-of-concept trial","volume":"16","author":"Qian","year":"2025","journal-title":"Front Pharmacol"},{"issue":"8","key":"2026082813453152600_ref8","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1111\/andr.13632","article-title":"Correlation between serum tryptophan metabolism and treatment efficacy of dapoxetine in patients with premature ejaculation: a pilot study","volume":"12","author":"Wu","year":"2024","journal-title":"Andrology"},{"issue":"1","key":"2026082813453152600_ref9","doi-asserted-by":"publisher","first-page":"e70077","DOI":"10.1002\/npr2.70077","article-title":"Safety of vortioxetine in patients with depression: a post-marketing surveillance study of intracranial hemorrhage in a Japanese Health Insurance Claims Database","volume":"46","author":"Takeshi","year":"2026","journal-title":"Neuropsychopharmacol Rep"},{"issue":"1","key":"2026082813453152600_ref10","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1186\/s12888-025-07445-4","article-title":"Maintenance pharmacotherapy after electroconvulsive therapy in inpatients with major depressive disorder: 198 prescriptions in a real-world clinical setting","volume":"25","author":"Igarashi","year":"2025","journal-title":"BMC Psychiatry"},{"key":"2026082813453152600_ref11","doi-asserted-by":"publisher","first-page":"116559","DOI":"10.1016\/j.psychres.2025.116559","article-title":"Lessons learned from the regulatory alignment in ketamine, esketamine and arketamine clinical trials: a cross-sectional analysis of protocols from ClinicalTrials.gov","volume":"350","author":"Swieczkowski","year":"2025","journal-title":"Psychiatry Res"},{"key":"2026082813453152600_ref12","doi-asserted-by":"publisher","first-page":"1702137","DOI":"10.3389\/fpsyt.2025.1702137","article-title":"Impact of difficult-to-treat depression for patients and society: a real-world study","volume":"16","author":"Sergio","year":"2025","journal-title":"Front Psychiatry"},{"key":"2026082813453152600_ref13","doi-asserted-by":"publisher","first-page":"103413","DOI":"10.1016\/j.eclinm.2025.103413","article-title":"Switch to mania after acute antidepressant treatment for bipolar depression: a systematic review and network meta-analysis of randomised controlled trials","volume":"87","author":"Oliva","year":"2025","journal-title":"EClinicalMedicine."},{"key":"2026082813453152600_ref14","doi-asserted-by":"publisher","first-page":"1593989","DOI":"10.3389\/fphar.2025.1593989","article-title":"Comparison of safety of lecanemab and aducanumab: a real-world disproportionality analysis using the FDA adverse event reporting system","volume":"16","author":"Kong","year":"2025","journal-title":"Front Pharmacol"},{"key":"2026082813453152600_ref15","doi-asserted-by":"publisher","first-page":"1524702","DOI":"10.3389\/fphar.2025.1524702","article-title":"Data mining and safety analysis of voriconazole in patients with a hematological malignant tumor based on the FAERS database: differences between children and adults","volume":"16","author":"Li","year":"2025","journal-title":"Front Pharmacol"},{"issue":"1","key":"2026082813453152600_ref16","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/ijd.17957","article-title":"Is the safety of finasteride correlated with its route of administration: topical versus oral? A pharmacovigilance study with data from the United States Food and Drug Administration Adverse Event Reporting System","volume":"65","author":"Gupta Aditya","year":"2026","journal-title":"Int J Dermatol"},{"key":"2026082813453152600_ref17","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.jad.2025.03.007","article-title":"Post-marketing safety evaluation of vortioxetine: a decade-long pharmacovigilance study based on the FAERS database","volume":"379","author":"Wu","year":"2025","journal-title":"J Affect Disord"},{"issue":"Pt B","key":"2026082813453152600_ref18","doi-asserted-by":"publisher","first-page":"120462","DOI":"10.1016\/j.jad.2025.120462","article-title":"Glucose dysregulation signals in weight-neutral atypical antipsychotics: a pharmacovigilance-pharmacodynamic evaluation of FAERS data","volume":"393","author":"Liyun","year":"2026","journal-title":"J Affect Disord"},{"issue":"6","key":"2026082813453152600_ref19","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s40264-024-01421-9","article-title":"The reporting of a disproportionality analysis for drug safety signal detection using individual case safety reports in PharmacoVigilance (READUS-PV): development and statement","volume":"47","author":"Fusaroli","year":"2024","journal-title":"Drug Saf"},{"issue":"6","key":"2026082813453152600_ref20","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s40264-024-01423-7","article-title":"The REporting of a disproportionality analysis for DrUg safety signal detection using individual case safety reports in PharmacoVigilance (READUS-PV): explanation and elaboration","volume":"47","author":"Fusaroli","year":"2024","journal-title":"Drug Saf"},{"key":"2026082813453152600_ref21","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbab347","article-title":"Detection algorithms and attentive points of safety signal using spontaneous reporting systems as a clinical data source","volume":"22","author":"Noguchi","year":"2021","journal-title":"Brief Bioinform"},{"issue":"4","key":"2026082813453152600_ref22","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.21873\/invivo.14007","article-title":"Time-to-onset analysis of rhabdomyolysis associated with selective serotonin and serotonin-noradrenaline reuptake inhibitors using the Japanese pharmacovigilance database","volume":"39","author":"Ohyama","year":"2025","journal-title":"In Vivo"},{"key":"2026082813453152600_ref23","doi-asserted-by":"publisher","first-page":"121041","DOI":"10.1016\/j.jad.2025.121041","article-title":"Neurological drugs induced congenital anomalies: a pharmacovigilance analysis of neonatal reports in the FDA adverse event reporting system (FAERS)","volume":"398","author":"Haiyan","year":"2025","journal-title":"J Affect Disord"},{"issue":"4","key":"2026082813453152600_ref24","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1007\/s43440-025-00730-9","article-title":"Non-response to short-term ketamine use for treatment-resistant depression","volume":"77","author":"Walaszek","year":"2025","journal-title":"Pharmacol Rep"},{"issue":"6","key":"2026082813453152600_ref25","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1177\/02698811241249651","article-title":"Unveiling potential adverse events associated with escitalopram oxalate: a real-world analysis based FDA adverse event reporting system database","volume":"38","author":"Jiang","year":"2024","journal-title":"J Psychopharmacol"},{"key":"2026082813453152600_ref26","doi-asserted-by":"publisher","first-page":"116388","DOI":"10.1016\/j.psychres.2025.116388","article-title":"A scientific approach to hemorrhage risk assessment of SSRIs\/SNRIs utilizing the FAERS database","volume":"346","author":"Zhou","year":"2025","journal-title":"Psychiatry Res"},{"issue":"3","key":"2026082813453152600_ref27","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.encep.2018.05.001","article-title":"Consequences of the monoaminergic systems cross-talk in the antidepressant activity","volume":"44","author":"Tritschler","year":"2018","journal-title":"Encephale."},{"key":"2026082813453152600_ref28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.neuint.2014.12.006","article-title":"Serotonin-2C antagonism augments the effect of citalopram on serotonin and dopamine levels in the ventral tegmental area and nucleus accumbens","volume":"81","author":"Visser Anniek","year":"2015","journal-title":"Neurochem Int"},{"key":"2026082813453152600_ref29","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000002210","article-title":"Antidepressant-induced sexual dysfunction in adults: a targeted scoping review and clinical update","author":"Zini","year":"2026","journal-title":"J Clin Psychopharmacol"},{"issue":"19","key":"2026082813453152600_ref30","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.3390\/healthcare13192433","article-title":"The off-label use of selective serotonin reuptake inhibitors for sexual behavior management: risks and considerations","volume":"13","author":"Shaw","year":"2025","journal-title":"Healthcare (Basel)"},{"key":"2026082813453152600_ref31","doi-asserted-by":"publisher","DOI":"10.1177\/09246479261468499","article-title":"Post-SSRI sexual dysfunction (PSSD): a comprehensive review of epidemiology, pathophysiology, and clinical management","author":"Mingfeng","year":"2026","journal-title":"Int J Risk Saf Med"},{"issue":"2","key":"2026082813453152600_ref32","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/sj.ijir.3900950","article-title":"Vardenafil reverses erectile dysfunction induced by paroxetine in rats","volume":"15","author":"Angulo","year":"2003","journal-title":"Int J Impot Res"},{"key":"2026082813453152600_ref33","doi-asserted-by":"publisher","DOI":"10.1093\/reprod\/xaag036","article-title":"Asprosin infusion modulates central circuits to rescue selective serotonin reuptake inhibitor-induced male dysfunction","volume":"171","author":"Tan","year":"2026","journal-title":"Reproduction."},{"issue":"6","key":"2026082813453152600_ref34","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1111\/andr.13770","article-title":"Effect of antidepressants on ejaculation dysfunction in patients with depression and anxiety: a systematic review and network meta-analysis","volume":"13","author":"Wang","year":"2025","journal-title":"Andrology."},{"issue":"1","key":"2026082813453152600_ref35","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1186\/s12888-025-06751-1","article-title":"Antidepressant-associated sexual dysfunction in outpatients","volume":"25","author":"Safak","year":"2025","journal-title":"BMC Psychiatry"},{"issue":"6","key":"2026082813453152600_ref36","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41443-024-00937-z","article-title":"A population analysis of delayed ejaculation using a claims database: characteristics and national trends in prevalence, incidence, and pharmacotherapy","volume":"37","author":"Liao","year":"2025","journal-title":"Int J Impot Res"},{"key":"2026082813453152600_ref37","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s40001-025-03676-z","article-title":"Safety assessment of ustekinumab in inflammatory bowel disease: a real-world analysis based on the FDA adverse event reporting system (FAERS)","volume":"31","author":"Likang","year":"2025","journal-title":"Eur J Med Res"},{"key":"2026082813453152600_ref38","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jare.2023.05.008","article-title":"Insights into modifiable risk factors of erectile dysfunction, a wide-angled Mendelian Randomization study","volume":"58","author":"Xiong","year":"2024","journal-title":"J Adv Res"},{"issue":"4","key":"2026082813453152600_ref39","doi-asserted-by":"publisher","first-page":"299","DOI":"10.4088\/pcc.v10n0405","article-title":"Major depressive disorder, obsessive-compulsive disorder, and generalized anxiety disorder: do the sexual dysfunctions differ?","volume":"10","author":"Kendurkar","year":"2008","journal-title":"Prim Care Companion J Clin Psychiatry"},{"issue":"6","key":"2026082813453152600_ref40","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1111\/j.1743-6109.2012.02709.x","article-title":"Bidirectional association between depression and sexual dysfunction: a systematic review and meta-analysis","volume":"9","author":"Atlantis","year":"2012","journal-title":"J Sex Med"},{"key":"2026082813453152600_ref41","doi-asserted-by":"publisher","first-page":"1224959","DOI":"10.3389\/fnins.2023.1224959","article-title":"A new approach to 'on-demand' treatment of lifelong premature ejaculation by treatment with a combination of a 5-HT1A receptor antagonist and SSRI in rats","volume":"17","author":"Olivier","year":"2023","journal-title":"Front Neurosci"},{"issue":"7","key":"2026082813453152600_ref42","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1002\/phar.2767","article-title":"Adverse effects of antidepressant medications and their Management in Children and Adolescents","volume":"43","author":"Strawn","year":"2023","journal-title":"Pharmacotherapy."},{"key":"2026082813453152600_ref43","doi-asserted-by":"publisher","first-page":"4470169","DOI":"10.1155\/da\/4470169","article-title":"Clinical and treatment characteristics of 3795 adults consecutively hospitalized for major depressive disorder in the OASIS-D study","volume":"2025","author":"N\u00f6hles Viktor","year":"2025","journal-title":"Depress Anxiety"},{"issue":"4","key":"2026082813453152600_ref44","doi-asserted-by":"publisher","first-page":"e81912","DOI":"10.7759\/cureus.81912","article-title":"Comparison of adverse events among angiotensin receptor blockers in hypertension using the United States Food and Drug Administration adverse event reporting system","volume":"17","author":"Ogura","year":"2025","journal-title":"Cureus."},{"issue":"1","key":"2026082813453152600_ref45","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/s12894-025-01973-7","article-title":"Comparative evaluation of safety and efficacy of dapoxetine, silodosin, and citalopram in the management of premature ejaculation: a randomized clinical trial","volume":"25","author":"Ahmed","year":"2025","journal-title":"BMC Urol"},{"issue":"1","key":"2026082813453152600_ref46","doi-asserted-by":"publisher","first-page":"10499","DOI":"10.1038\/s41598-025-95700-9","article-title":"Evaluation of atypical antipsychotics associated rhabdomyolysis using the FDA adverse event reporting system database","volume":"15","author":"Yin","year":"2025","journal-title":"Sci Rep"},{"issue":"1","key":"2026082813453152600_ref47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40264-024-01473-x","article-title":"Caveats of covariate adjustment in disproportionality analysis for best practices","volume":"48","author":"Noguchi","year":"2025","journal-title":"Drug Saf"}],"container-title":["Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/smoa\/article-pdf\/14\/5\/qfag082\/70831872\/qfag082.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/smoa\/article-pdf\/14\/5\/qfag082\/70831872\/qfag082.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T17:45:37Z","timestamp":1787939137000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/smoa\/article\/doi\/10.1093\/sexmed\/qfag082\/8772740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,7,2]]}},"URL":"https:\/\/doi.org\/10.1093\/sexmed\/qfag082","relation":{},"ISSN":["2050-1161"],"issn-type":[{"value":"2050-1161","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,7,2]]},"article-number":"qfag082"}}